ANTIOXIDANT STATUS AND THE IN VITRO EFFECT OF AMYLASE AND LIPASE ENZYMES ON IRAQI PANCREATIC CANCER PATIENTS

Authors

  • Maha Y. Thabeet Al-Nahrain University, College of Science, Dept. of Chemistry, Baghdad, Iraq.
  • Prof.Dr.Firas A. Hassan Al-Nahrain University, College of Science, Dept. of Chemistry, Baghdad, Iraq.

Keywords:

pancreatic, exhibited, study, Amylase

Abstract

cancer of the pancreas Pancreatic cancer has been identified as the 11th most prevalent cancer in the world. It is an incurable malignancy and the seventh major cause of cancer deaths globally in industrialized nations. 100 blood samples were obtained from AL-Anbar oncology cancer and the nearby Baghdad Hospital. Two groups were created out of them. The first group consists of 30 pancreatic cancer patients between the ages of 20 and 40, while the second group consists of 30 patients between the ages of 41 and 60, with 20 healthy individuals serving as the control group. Measurements were made to gather biological data to aid in the early diagnosis of the illness. The concentration of Amylase enzyme in the serum of pancreatic cancer patients increased, while the concentration of Lipase enzyme decreased when compared to the control group, according to the results of the measurements of the two groups' levels

References

Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249.

Buwenge M, Macchia G, Arcelli A, Frakulli R, Fuccio L, Guerri S, et al. Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief. J Pain Res. 2018;11:2169–78

Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709.

Athwal T, Huang W, Mukherjee R, Latawiec D, Chvanov M, Clarke R, Smith K, Campbell F, Merriman C, Criddle D, et al. Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death. Cell Death Dis. 2014;5:e1165.

Capello M, Fahrmann JF, Rios Perez MV, et al. CES2 Expression in pancreatic adenocarcinoma is predictive of response to irinotecan and is associated with type 2 diabetes. JCO Precis Oncol. 2020;4:426–36.

Tempero, M.A.; Reni, M.; Riess, H.; Pelzer, U.; O’Reilly, E.M.; Winter, J.M.; Oh, D.-Y.; Li, C.-P.; Tortora, G.;Chang, H.-M.; et al. APACT: Phase III, multicenter, international, open-label, randomized trial ofadjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreaticadenocarcinoma. J. Clin. Oncol. 2019,37 (Suppl. 15), 4000.

Downloads

Published

2022-08-24

How to Cite

Maha Y. Thabeet, & Prof.Dr.Firas A. Hassan. (2022). ANTIOXIDANT STATUS AND THE IN VITRO EFFECT OF AMYLASE AND LIPASE ENZYMES ON IRAQI PANCREATIC CANCER PATIENTS. World Bulletin of Public Health, 13, 172-175. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/1297

Issue

Vol. 13 (2022): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.